Mercaptopurine (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Mercaptopurine drug offered from Avera McKennan Hospital. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | Mercaptopurine |
SUBSTANCE NAME: | MERCAPTOPURINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-03-01 |
END MARKETING DATE: | 0000-00-00 |
Mercaptopurine HUMAN PRESCRIPTION DRUG Details:
Item Description | Mercaptopurine from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2015-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-4581_0c88e81e-20fd-4f09-9dd7-93a904eb1b6b |
PRODUCT NDC: | 69189-4581 |
APPLICATION NUMBER: | ANDA040528 |
Other MERCAPTOPURINE Pharmaceutical Manufacturers / Labelers: